In contrast, the divergence in expression observed for GSK3B and PIK3CD between lymphomas and cell lines is likely due to clonal selection or cultivation induced artifacts, hence limiting the value of the cell lines as drug testing system. This evidence concerns the gene PIK3CD and lymphoma.